KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Castle Biosciences (CSTL) Operating Margin (2018 - 2025)

Historic Operating Margin for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to 8.19%.

  • Castle Biosciences' Operating Margin fell 141100.0% to 8.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 10.17%, marking a year-over-year decrease of 98400.0%. This contributed to the annual value of 2.61% for FY2024, which is 335400.0% up from last year.
  • As of Q3 2025, Castle Biosciences' Operating Margin stood at 8.19%, which was down 141100.0% from 4.93% recorded in Q2 2025.
  • Castle Biosciences' 5-year Operating Margin high stood at 5.92% for Q3 2024, and its period low was 91.3% during Q1 2022.
  • Over the past 5 years, Castle Biosciences' median Operating Margin value was 18.78% (recorded in 2021), while the average stood at 29.8%.
  • Per our database at Business Quant, Castle Biosciences' Operating Margin tumbled by -725200bps in 2022 and then soared by 674900bps in 2024.
  • Over the past 5 years, Castle Biosciences' Operating Margin (Quarter) stood at 60.59% in 2021, then rose by 2bps to 59.55% in 2022, then surged by 86bps to 8.56% in 2023, then skyrocketed by 155bps to 4.69% in 2024, then crashed by -275bps to 8.19% in 2025.
  • Its last three reported values are 8.19% in Q3 2025, 4.93% for Q2 2025, and 31.74% during Q1 2025.